Contribution of Noncovalent Recognition and Reactivity to the Optimization of Covalent Inhibitors: A Case Study on KRasG12C.

ARS-1620 - Kura Oncology, J&J, Araxes Pharma

http://www.ncbi.nlm.nih.gov/pubmed/38991015

András Perczel; Attila Egyed; Gitta Schlosser; György G Ferenczy; Jozsef Tovari; László Buday; László Petri; Levente M Mihalovits; Márton Gadanecz; Nikolett Péczka; Noémi Csorba; Péter Ábrányi-Balogh; Tamás Takács; Zoltán Orgován

Jul 11, 2024